A detailed history of Empowered Funds, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Empowered Funds, LLC holds 97,178 shares of ABBV stock, worth $17 Million. This represents 0.26% of its overall portfolio holdings.

Number of Shares
97,178
Previous 81,244 19.61%
Holding current value
$17 Million
Previous $16 Million 7.63%
% of portfolio
0.26%
Previous 0.26%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Jan 28, 2025

BUY
$164.99 - $203.87 $2.63 Million - $3.25 Million
15,934 Added 19.61%
97,178 $17.3 Million
Q3 2024

Nov 06, 2024

SELL
$163.84 - $199.33 $1.53 Million - $1.87 Million
-9,361 Reduced 10.33%
81,244 $16 Million
Q2 2024

Jul 30, 2024

BUY
$154.79 - $180.76 $7.06 Million - $8.24 Million
45,606 Added 101.35%
90,605 $15.5 Million
Q1 2024

May 06, 2024

SELL
$159.82 - $182.1 $3.86 Million - $4.4 Million
-24,146 Reduced 34.92%
44,999 $8.19 Million
Q3 2023

Nov 01, 2023

BUY
$133.59 - $154.65 $6.19 Million - $7.17 Million
46,348 Added 203.31%
69,145 $10.3 Million
Q2 2023

Jul 27, 2023

BUY
$132.51 - $164.9 $9,540 - $11,872
72 Added 0.32%
22,797 $3.07 Million
Q1 2023

Apr 05, 2023

BUY
$144.61 - $166.54 $518,860 - $597,545
3,588 Added 18.75%
22,725 $3.62 Million
Q4 2022

Jan 26, 2023

BUY
$138.31 - $165.87 $1.48 Million - $1.77 Million
10,701 Added 126.85%
19,137 $3.09 Million
Q3 2022

Nov 04, 2022

SELL
$134.21 - $153.93 $1.37 Million - $1.57 Million
-10,214 Reduced 54.77%
8,436 $1.13 Million
Q2 2022

Aug 01, 2022

BUY
$137.62 - $174.96 $1.74 Million - $2.21 Million
12,630 Added 209.8%
18,650 $2.86 Million
Q1 2022

Apr 21, 2022

BUY
$131.98 - $163.75 $27,979 - $34,715
212 Added 3.65%
6,020 $976,000
Q4 2021

Feb 10, 2022

BUY
$107.43 - $135.93 $81,969 - $103,714
763 Added 15.12%
5,808 $786,000
Q3 2021

Nov 12, 2021

BUY
$106.4 - $120.78 $235,037 - $266,803
2,209 Added 77.89%
5,045 $544,000
Q2 2021

Aug 04, 2021

BUY
$105.21 - $117.21 $298,375 - $332,407
2,836 New
2,836 $319,000
Q4 2019

Jan 27, 2020

SELL
$72.13 - $90.25 $2.33 Million - $2.91 Million
-32,296 Closed
0 $0
Q3 2019

Nov 01, 2019

BUY
$62.98 - $75.72 $2.03 Million - $2.45 Million
32,296 New
32,296 $2.45 Million
Q2 2018

Jul 09, 2018

SELL
$89.78 - $106.23 $922,579 - $1.09 Million
-10,276 Closed
0 $0
Q1 2018

Apr 25, 2018

BUY
$92.01 - $123.21 $34,503 - $46,203
375 Added 3.79%
10,276 $969,000
Q4 2017

Jul 09, 2018

BUY
$89.56 - $98.21 $886,733 - $972,377
9,901
9,901 $958,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $309B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Empowered Funds, LLC Portfolio

Follow Empowered Funds, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Empowered Funds, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Empowered Funds, LLC with notifications on news.